Question 1

Has Teresa Gentile, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $591,683 in general payments to Teresa Gentile, MD across 56 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Teresa Gentile, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Teresa Gentile, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novartis	4	$165,073
Otsuka Pharmaceutical Co., Ltd.	6	$159,247
Janssen Research & Development, LLC	11	$92,052
Syndax Pharmaceuticals, Inc.	5	$75,543
Morphosys AG	2	$37,250
Astellas Pharma Global Development	2	$29,349
Taiho Oncology, Inc.	1	$20,690
Pharmacyclics LLC, An Abbvie Company	21	$8,950
TG Therapeutics, Inc.	2	$3,500
E.r. Squibb & Sons, L.L.C.	2	$29

Teresa Gentile, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other hematology & oncology in Syracuse